Clinical Trial Update: A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction [Phase 2]

View source ↗

Summary

A single-blind Phase 2 pilot study evaluated the safety and tolerability of the chymase inhibitor BAY1142524 in clinically stable patients with left-ventricular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• BAY1142524

Snippet

Sponsor: Bayer | Conditions: Heart Failure | Phase 2 | Status: COMPLETED